{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:08:26Z","timestamp":1793311706328,"version":"4.5.0"},"reference-count":196,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["RS2024\\u201302"],"award-info":[{"award-number":["RS2024\\u201302"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.critrevonc.2025.104920","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T15:43:18Z","timestamp":1756914198000},"page":"104920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Unlocking the therapeutic potential of HDAC inhibitors in colorectal cancer: Mechanisms, efficacy, and future perspectives"],"prefix":"10.1016","volume":"215","author":[{"given":"Yedu","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanlong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.critrevonc.2025.104920_bib1","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbrc.2019.11.155","article-title":"Blockade of myeloid-derived suppressor cell function by valproic acid enhanced anti-PD-L1 tumor immunotherapy[J]","volume":"522","author":"Adeshakin","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104920_bib2","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1021\/acs.jmedchem.0c01676","article-title":"Dissecting histone deacetylase 3 in multiple disease conditions: selective inhibition as a promising therapeutic Strategy[J]","volume":"64","author":"Adhikari","year":"2021","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104920_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103669","article-title":"Immunotherapy and immunoevasion of colorectal cancer[J]","volume":"28","author":"Al Zein","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.critrevonc.2025.104920_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2017.04.003","article-title":"Unlocking the chromatin of adenoid cystic carcinomas using HDAC inhibitors sensitize cancer stem cells to cisplatin and induces tumor senescence[J]","volume":"21","author":"Almeida","year":"2017","journal-title":"Stem Cell Res."},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104920_bib5","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in Microsatellite-Instability-High advanced colorectal Cancer[J]","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104920_bib6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s13238-018-0602-z","article-title":"Developing potent PROTACs tools for selective degradation of HDAC6 protein[J]","volume":"10","author":"An","year":"2019","journal-title":"Protein Cell"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104920_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2025.01.003","article-title":"A cis-regulatory element controls expression of histone deacetylase 9 to fine-tune inflammasome-dependent chronic inflammation in atherosclerosis[J]","volume":"58","author":"Asare","year":"2025","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104920_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189150","article-title":"Histone deacetylase complexes: structure, regulation and function[J]","volume":"1879","author":"Asmamaw","year":"2024","journal-title":"Biochim. Et. Biophys. Acta Rev. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104920_bib9","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s12013-025-01670-0","article-title":"Histone deacetylation in alzheimer's diseases (AD); hope or Hype[J]","volume":"83","author":"Ateya","year":"2025","journal-title":"Cell Biochem. Biophys."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104920_bib10","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/s41375-018-0062-8","article-title":"Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic t lymphocytes against multiple myeloma and solid tumors[J]","volume":"32","author":"Bae","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib11","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1038\/s41467-024-48724-0","article-title":"HDAC activity is dispensable for repression of cell-cycle genes by DREAM and E2F:RB complexes[J]","volume":"15","author":"Barrett","year":"2024","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104920_bib12","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/s41401-025-01523-9","article-title":"Endothelial histone deacetylase 9 promotes diabetic retinopathy in mice by regulating endothelial-mesenchymal transition[J]","volume":"46","author":"Bei","year":"2025","journal-title":"Acta Pharmacol. Sin."},{"issue":"2 D","key":"10.1016\/j.critrevonc.2025.104920_bib13","article-title":"Colon cancer, version 3.2024, NCCN clinical practice guidelines in Oncology[J]","volume":"22","author":"Benson","year":"2024","journal-title":"Journal National Comprehensive Cancer Network JNCCN"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104920_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/biom9020060","article-title":"The ROMP: a powerful approach to synthesize novel pH-Sensitive nanoparticles for tumor Therapy[J]","volume":"9","author":"Bertrand","year":"2019","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104920_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70656","article-title":"A model of butyrate activity and resistance in CRC[J]","volume":"29","author":"Bordonaro","year":"2025","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104920_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11864-017-0456-2","article-title":"Treatment of Relapsed\/Refractory acute myeloid Leukemia[J]","volume":"18","author":"Bose","year":"2017","journal-title":"Curr. Treat. Options Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104920_bib17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00262-017-2091-y","article-title":"The class I\/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy[J]","volume":"67","author":"Briere","year":"2018","journal-title":"Cancer Immunology Immunotherapy CII"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/acs.jmedchem.9b00924","article-title":"Old but gold: tracking the new guise of histone deacetylase 6 (HDAC6) enzyme as a biomarker and therapeutic target in rare Diseases[J]","volume":"63","author":"Brindisi","year":"2020","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104920_bib19","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1182\/blood-2010-08-303701","article-title":"HDAC11 plays an essential role in regulating OX40 ligand expression in hodgkin lymphoma[J]","volume":"117","author":"Buglio","year":"2011","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.critrevonc.2025.104920_bib20","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1021\/jm800873k","article-title":"Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells[J]","volume":"51","author":"Campbell","year":"2008","journal-title":"J. Med. Chem."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104920_bib21","doi-asserted-by":"crossref","first-page":"8467","DOI":"10.1128\/MCB.24.19.8467-8476.2004","article-title":"Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development[J]","volume":"24","author":"Chang","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104920_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2006.05.040","article-title":"Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10[J]","volume":"126","author":"Chang","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2025.104920_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2815187","article-title":"HDAC8 promotes liver metastasis of colorectal cancer via inhibition of IRF1 and upregulation of SUCNR1[J]","volume":"2022","author":"Chen","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104920_bib24","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1016\/j.bmc.2008.03.050","article-title":"Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group[J]","volume":"16","author":"Chen","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104920_bib25","article-title":"PJA2 suppresses colorectal cancer progression by controlling HDAC2 degradation and Stability[J]","volume":"12","author":"Chen","year":"2025","journal-title":"Advanced Science (Weinheim BadenWurttemberg Germany)"},{"key":"10.1016\/j.critrevonc.2025.104920_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120455","article-title":"HDAC3 in neurodevelopmental disorders: molecular mechanisms and targeted intervention[J]","volume":"577","author":"Chourri","year":"2025","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104920_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17132102","article-title":"Overcoming barriers in cancer biology research: current limitations and Solutions[J]","volume":"17","author":"Colonna","year":"2025","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2020.03.011","article-title":"How RNA-Binding proteins interact with RNA: molecules and Mechanisms[J]","volume":"78","author":"Corley","year":"2020","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104920_bib29","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1093\/nar\/gkae036","article-title":"Structural insights into the HDAC4-MEF2A-DNA complex and its implication in long-range transcriptional regulation[J]","volume":"52","author":"Dai","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104920_bib30","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/1535-7163.MCT-18-1068","article-title":"HDAC3 inhibition upregulates PD-L1 expression in B-Cell lymphomas and augments the efficacy of Anti-PD-L1 Therapy[J]","volume":"18","author":"Deng","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40170-025-00391-5","article-title":"Identification and impact of microbiota-derived metabolites in ascites of ovarian and gastrointestinal cancer[J]","volume":"13","author":"Deng","year":"2025","journal-title":"Cancer Metab."},{"key":"10.1016\/j.critrevonc.2025.104920_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.144340","article-title":"Construction of polydopamine nanomedicine for dual inhibition and degradation of histone deacetylases in cancer cells[J]","volume":"313","author":"Ding","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104920_bib33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00280-012-1847-5","article-title":"Phase I study of chidamide (CS055\/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas[J]","volume":"69","author":"Dong","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"31","key":"10.1016\/j.critrevonc.2025.104920_bib34","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1200\/JCO.2009.27.4860","article-title":"Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study[J]","volume":"28","author":"Douillard","year":"2010","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104920_bib35","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/glia.23567","article-title":"Differential roles of epigenetic regulators in the survival and differentiation of oligodendrocyte precursor cells[J]","volume":"67","author":"Egawa","year":"2019","journal-title":"Glia"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104920_bib36","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1021\/jm801661m","article-title":"Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery[J]","volume":"52","author":"Elmouelhi","year":"2009","journal-title":"J. Med. Chem."},{"issue":"33","key":"10.1016\/j.critrevonc.2025.104920_bib37","doi-asserted-by":"crossref","first-page":"30145","DOI":"10.1021\/acsomega.3c02681","article-title":"Differences and similarities between colorectal cancer cells and colorectal cancer stem cells: molecular insights and Implications[J]","volume":"8","author":"Erisik","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.critrevonc.2025.104920_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114409","article-title":"Azetidin-2-one-based small molecules as dual hHDAC6\/HDAC8 inhibitors: investigation of their mechanism of action and impact of dual inhibition profile on cell viability[J]","volume":"238","author":"Federico","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib39","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1186\/s12885-024-12508-y","article-title":"Mindfulness intervention, homogeneous medical concept, and concentrated solution nursing for colorectal cancer patients: a retrospective study[J]","volume":"24","author":"Feng","year":"2024","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104920_bib40","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.devcel.2020.06.036","article-title":"Metabolites regulate cell signaling and growth via covalent modification of Proteins[J]","volume":"54","author":"Figlia","year":"2020","journal-title":"Dev. Cell"},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104920_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300655","article-title":"Uracil- and Pyridine-Containing HDAC inhibitors displayed cytotoxicity in colorectal and glioblastoma cancer stem Cells[J]","volume":"19","author":"Fiorentino","year":"2024","journal-title":"ChemMedChem"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104920_bib42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41575-019-0126-x","article-title":"Immunotherapy in colorectal cancer: rationale, challenges and potential[J]","volume":"16","author":"Ganesh","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"14","key":"10.1016\/j.critrevonc.2025.104920_bib43","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1093\/nar\/gkae501","article-title":"HDAC4 influences the DNA damage response and counteracts senescence by assembling with HDAC1\/HDAC2 to control H2BK120 acetylation and homology-directed repair[J]","volume":"52","author":"Di Giorgio","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.critrevonc.2025.104920_bib44","article-title":"Nanocarrier mediated entinostat and oxaliplatin combination therapy displayed enhanced efficacy against pancreatic cancer[J]","volume":"175","author":"Giri","year":"2024","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"issue":"20","key":"10.1016\/j.critrevonc.2025.104920_bib45","doi-asserted-by":"crossref","first-page":"32918","DOI":"10.18632\/oncotarget.16464","article-title":"A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma[J]","volume":"8","author":"Goncalves","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104920_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1692","article-title":"Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3\/GSDMD-mediated pyroptosis in colorectal cancer[J]","volume":"14","author":"Guan","year":"2024","journal-title":"Clin. Transl. Med."},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104920_bib47","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.7150\/ijbs.73264","article-title":"TMP195 exerts antitumor effects on colorectal cancer by promoting M1 macrophages Polarization[J]","volume":"18","author":"Han","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104920_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177620","article-title":"Harnessing histone deacetylase inhibitors for enhanced cancer immunotherapy[J]","volume":"997","author":"Hedayat","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib49","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41467-025-55835-9","article-title":"Hypoxia-induced conversion of sensory schwann cells into repair cells is regulated by HDAC8[J]","volume":"16","author":"Hertzog","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.104920_bib50","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.yjmcc.2020.05.018","article-title":"Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5[J]","volume":"145","author":"He","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"14","key":"10.1016\/j.critrevonc.2025.104920_bib51","article-title":"HDAC2-Mediated METTL3 delactylation promotes DNA damage repair and chemotherapy resistance in Triple-Negative breast Cancer[J]","volume":"12","author":"He","year":"2025","journal-title":"Adv. Sci. (Weinheim Baden-Wurttemberg Germany)"},{"key":"10.1016\/j.critrevonc.2025.104920_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.878639","article-title":"PRL-3 and MMP9 expression and Epithelial-Mesenchymal transition markers in circulating tumor cells from patients with colorectal cancer: potential value in clinical Practice[J]","volume":"12","author":"Hong","year":"2022","journal-title":"Front. Oncol."},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104920_bib53","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2500176122","article-title":"A mouse model of jansen's metaphyseal chondrodysplasia for investigating disease mechanisms and candidate therapeutics[J]","volume":"122","author":"H\u00f6ppner","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"10.1016\/j.critrevonc.2025.104920_bib54","doi-asserted-by":"crossref","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","article-title":"Thirty years of HDAC inhibitors: 2020 insight and Hindsight[J]","volume":"63","author":"Ho","year":"2020","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104920_bib55","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41419-022-05256-z","article-title":"LncRNA SNHG1 regulates neuroblastoma cell fate via interactions with HDAC1\/2[J]","volume":"13","author":"Hsu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41419-025-07457-8","article-title":"Transcription factor ONECUT3 regulates HDAC6\/HIF-1\u03b1 activity to promote the warburg effect and tumor growth in colorectal cancer[J]","volume":"16","author":"Huo","year":"2025","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104920_bib57","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.pan.2019.01.011","article-title":"HDAC3 modulates cancer immunity via increasing PD-L1 expression in pancreatic cancer[J]","volume":"19","author":"Hu","year":"2019","journal-title":"Pancreatol. Off. J. Int. Assoc. Pancreatol. (IAP) \u2026 [Et. Al. ]"},{"key":"10.1016\/j.critrevonc.2025.104920_bib58","doi-asserted-by":"crossref","DOI":"10.5483\/BMBRep.2024-0122","article-title":"Contribution of histone deacetylases (HDACs) to the regulation of histone and non-histone proteins: implications for fibrotic diseases[J]","author":"Jang","year":"2025","journal-title":"BMB Rep."},{"issue":"24","key":"10.1016\/j.critrevonc.2025.104920_bib59","doi-asserted-by":"crossref","first-page":"16502","DOI":"10.1074\/jbc.M512494200","article-title":"Bone morphogenetic protein-2 stimulates Runx2 acetylation[J]","volume":"281","author":"Jeon","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.critrevonc.2025.104920_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149806","article-title":"Inhibition of class IIa HDACs reduces neuroinflammation via NEU1-LAMP1 regulation and promotes M2 macrophage polarization in ischemic stroke[J]","volume":"1864","author":"Jiang","year":"2025","journal-title":"Brain Res."},{"key":"10.1016\/j.critrevonc.2025.104920_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116634","article-title":"Biological function and small molecule inhibitors of histone deacetylase 11[J]","volume":"276","author":"Jia","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2025.104920_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1590219","article-title":"Radiation therapy induced intestinal barrier damage and repair process - differences in salivary metabolites and monitoring of intestinal barrier function[J]","volume":"16","author":"Jingjing","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib63","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/s41467-022-30143-8","article-title":"The immune checkpoint B7x expands tumor-infiltrating tregs and promotes resistance to anti-CTLA-4 therapy[J]","volume":"13","author":"John","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2025.104920_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216065","article-title":"PROTACs: promising approach for anticancer therapy[J]","volume":"556","author":"Kaur","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2025.104920_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116312","article-title":"Unraveling HDAC11: epigenetic orchestra in different diseases and structural insights for inhibitor design[J]","volume":"225","author":"Khatun","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib66","doi-asserted-by":"crossref","first-page":"F61","DOI":"10.1152\/ajprenal.00015.2013","article-title":"Gender-specific role of HDAC11 in kidney ischemia- and reperfusion-induced PAI-1 expression and injury[J]","volume":"305","author":"Kim","year":"2013","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104920_bib67","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.31083\/j.rcm2203113","article-title":"Histone deacetylase inhibitor, mocetinostat, regulates cardiac remodelling and renin-angiotensin system activity in rats with transverse aortic constriction-induced pressure overload cardiac hypertrophy[J]","volume":"22","author":"Kim","year":"2021","journal-title":"Rev. Cardiovasc. Med."},{"issue":"46","key":"10.1016\/j.critrevonc.2025.104920_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adp3687","article-title":"The HDAC6 inhibitor AVS100 (SS208) induces a pro-inflammatory tumor microenvironment and potentiates immunotherapy[J]","volume":"10","author":"Kovalovsky","year":"2024","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010098","article-title":"The class I HDAC inhibitor, MS-275, prevents Oxaliplatin-Induced chronic neuropathy and potentiates its antiproliferative activity in Mice[J]","volume":"23","author":"Lamoine","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104920_bib70","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/jcmm.12850","article-title":"Vimentin, colon cancer progression and resistance to butyrate and other HDACis[J]","volume":"20","author":"Lazarova","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.critrevonc.2025.104920_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109778","article-title":"A novel HDAC1\/2 inhibitor suppresses colorectal cancer through apoptosis induction and cell cycle regulation[J]","volume":"352","author":"Lee","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.critrevonc.2025.104920_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102179","article-title":"Distinct biochemical properties of the class I histone deacetylase complexes[J]","volume":"70","author":"Lee","year":"2022","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib73","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41392-025-02290-z","article-title":"Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3\/c-MYC axis[J]","volume":"10","author":"Lepore Signorile","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1200\/JCO.19.02107","article-title":"Phase II Open-Label study of pembrolizumab in Treatment-Refractory, microsatellite Instability-High\/Mismatch Repair-Deficient metastatic colorectal cancer: KEYNOTE-164[J]","volume":"38","author":"Le","year":"2020","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104920_bib75","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jpha.2023.06.005","article-title":"Histone deacetylase inhibitor pracinostat suppresses colorectal cancer by inducing CDK5-Drp1 signaling-mediated peripheral mitofission[J]","volume":"13","author":"Liang","year":"2023","journal-title":"J. Pharm. Anal."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104920_bib76","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/imm.13939","article-title":"Intestinal butyrate ameliorates rheumatoid arthritis through promoting the expression of cortistatin in ileum via HDAC3-Vitamin d receptor Pathway[J]","volume":"175","author":"Liao","year":"2025","journal-title":"Immunology"},{"key":"10.1016\/j.critrevonc.2025.104920_bib77","article-title":"Chemical perturbations impacting histone acetylation govern colorectal cancer Differentiation[J]","author":"Likasitwatanakul","year":"2025","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib78","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13045-024-01624-8","article-title":"Tucidinostat plus pediatric-inspired chemotherapy for newly diagnosed adult ETP-ALL\/LBL: a single-arm, phase 2 trial[J]","volume":"17","author":"Lin","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104920_bib79","article-title":"HDAC11: a novel target for improved cancer therapy[J]","volume":"166","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104920_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188447","article-title":"Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: from bench to bedside[J]","volume":"1874","author":"Lizardo","year":"2020","journal-title":"Biochim. Et. Biophys. Acta Rev. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104920_bib81","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s41419-020-02968-y","article-title":"Checkpoint regulator B7x is epigenetically regulated by HDAC3 and mediates resistance to HDAC inhibitors by reprogramming the tumor immune environment in colorectal cancer[J]","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib82","article-title":"Design and synthesis of thiazole-based hydroxamate histone deacetylase inhibitors with potent antitumor efficacy by inducing apoptosis, pyroptosis and cell cycle arrest[J]","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104920_bib83","first-page":"466","article-title":"Molecular insights into immune evasion and therapeutic paradigms in pancreatic cancer[J]","volume":"37","author":"Li","year":"2025","journal-title":"Chin. J. Cancer Res. = Chungkuo Yen Cheng Yen Chiu"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104920_bib84","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00262-018-2283-0","article-title":"Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor belinostat in a murine hepatocellular carcinoma model[J]","volume":"68","author":"Llopiz","year":"2019","journal-title":"Cancer Immunology Immunotherapy CII"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib85","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70193","article-title":"Pathogenic variants of TUBB8 cause oocyte spindle defects by disrupting with EB1\/CAKP5 interactions and potential treatment targeting microtubule acetylation through HDAC6 inhibition[J]","volume":"15","author":"Luo","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.critrevonc.2025.104920_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177781","article-title":"Fecal microbiota transplantation alleviates cirrhotic portal hypertension in rats via butyrate-mediated HDAC3 inhibition and PI3K\/Akt\/eNOS signaling regulation[J]","volume":"1002","author":"Luo","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104920_bib87","first-page":"664","article-title":"Histone modifiers and marks define heterogeneous groups of colorectal carcinomas and affect responses to HDAC inhibitors in vitro[J]","volume":"6","author":"Lutz","year":"2016","journal-title":"Am. J. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104920_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.576","article-title":"Tweety homolog 3 promotes colorectal cancer progression through mutual regulation of histone deacetylase 7[J]","volume":"5","author":"Lu","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.critrevonc.2025.104920_bib89","article-title":"ABHD5 protects cardiac function in alcoholic cardiomyopathy via HDAC4-NT to inhibit CAMKII\/MEF2 axis[J]","author":"Lv","year":"2023","journal-title":"J. Appl. Physiol. (Bethesda Md. 1985)"},{"key":"10.1016\/j.critrevonc.2025.104920_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155533","article-title":"Bioinformatic analysis of the molecular targets of curcumin in colorectal cancer[J]","volume":"262","author":"Mahmoudi","year":"2024","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib91","doi-asserted-by":"crossref","DOI":"10.2174\/1568009617666170206104032","article-title":"Mechanisms for the inhibition of colon cancer cells by sulforaphane through epigenetic modulation of MicroRNA-21 and human telomerase reverse transcriptase (hTERT) Down-regulation[J]","volume":"18","author":"Martin","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104920_bib92","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.immuni.2018.03.010","article-title":"A developmental switch in microglial HDAC Function[J]","volume":"48","author":"Mathys","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2025.104920_bib93","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/bs.acr.2018.02.006","article-title":"Advances and challenges of HDAC inhibitors in cancer Therapeutics[J]","volume":"138","author":"McClure","year":"2018","journal-title":"Adv. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104920_bib94","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nn1408","article-title":"Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression[J]","volume":"8","author":"M\u00e9jat","year":"2005","journal-title":"Nat. Neurosci."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104920_bib95","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1093\/nar\/gkac081","article-title":"Transcriptomic and genomic studies classify NKL54 as a histone deacetylase inhibitor with indirect influence on MEF2-dependent transcription[J]","volume":"50","author":"Minisini","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104920_bib96","first-page":"1164","article-title":"Short chain fatty acid sodium butyrate increases miR-21, miR-143 and miR-145 expression in human colorectal cancer HCT-116 cell Line[J]","volume":"53","author":"Mohammadi","year":"2024","journal-title":"Iran. J. Public Health"},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104920_bib97","doi-asserted-by":"crossref","first-page":"9366","DOI":"10.1073\/pnas.93.18.9366","article-title":"Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors[J]","volume":"93","author":"Molkentin","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.critrevonc.2025.104920_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110133","article-title":"B7x in cancer immunity and immunotherapy[J]","volume":"118","author":"Mortezaee","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"24","key":"10.1016\/j.critrevonc.2025.104920_bib99","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151713","article-title":"Plasma cell dependence on histone\/protein deacetylase 11 reveals a therapeutic target in multiple myeloma[J]","volume":"6","author":"Mostofa","year":"2021","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104920_bib100","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1021\/acs.chemrestox.4c00551","article-title":"HDAC6-Mediated NLRP3 inflammasome activation is involved in nickel Nanoparticle-Induced pulmonary inflammation and Fibrosis[J]","volume":"38","author":"Mo","year":"2025","journal-title":"Chem. Res. Toxicol."},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104920_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158250","article-title":"Interactions between dietary antioxidants, dietary fiber and the gut microbiome: their putative role in inflammation and Cancer[J]","volume":"25","author":"Munteanu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104920_bib102","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1158\/0008-5472.CAN-23-2742","article-title":"Ketogenic diet alters the epigenetic and immune landscape of prostate cancer to overcome resistance to immune checkpoint blockade Therapy[J]","volume":"84","author":"Murphy","year":"2024","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104920_bib103","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41580-018-0081-3","article-title":"Functions and mechanisms of non-histone protein acetylation[J]","volume":"20","author":"Narita","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104920_bib104","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41571-021-00495-z","article-title":"Precision oncology in metastatic colorectal cancer - from biology to Medicine[J]","volume":"18","author":"Di Nicolantonio","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2025.104920_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.935500","article-title":"Clinical significance of serum haptoglobin and protein Disulfide-Isomerase A3 in the screening, diagnosis, and staging of colorectal Cancer[J]","volume":"13","author":"Niu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib106","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1158\/1078-0432.CCR-08-0684","article-title":"Histone deacetylase 8 in neuroblastoma tumorigenesis[J]","volume":"15","author":"Oehme","year":"2009","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104920_bib107","article-title":"Clinical efficacy and mechanistic insights of FDA-approved HDAC inhibitors in the treatment of lymphoma[J]","volume":"208","author":"El Omari","year":"2025","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.critrevonc.2025.104920_bib108","article-title":"Anticancer clinical efficiency and stochastic mechanisms of belinostat[J]","volume":"165","author":"El Omari","year":"2023","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"issue":"17","key":"10.1016\/j.critrevonc.2025.104920_bib109","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1158\/1078-0432.CCR-17-0741","article-title":"Entinostat neutralizes Myeloid-Derived suppressor cells and enhances the antitumor effect of PD-1 inhibition in murine models of lung and renal cell Carcinoma[J]","volume":"23","author":"Orillion","year":"2017","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104920_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27196247","article-title":"Inhibition of MORC2 mediates HDAC4 to promote cellular senescence through p53\/p21 signaling Axis[J]","volume":"27","author":"Ou","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104920_bib111","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","article-title":"Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch Repair-Deficient\/Microsatellite Instability-High metastatic colorectal Cancer[J]","volume":"36","author":"Overman","year":"2018","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104920_bib112","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study[J]","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2025.104920_bib113","doi-asserted-by":"crossref","DOI":"10.1007\/s10637-025-01559-y","article-title":"Targeting neuroblastoma with hydroxamic acid based HDAC1 and HDAC2 inhibitors: insights from in vitro and in vivo studies[J]","author":"Pai","year":"2025","journal-title":"Investig. N. Drugs"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104920_bib114","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2174\/0929867327666200203113926","article-title":"Romidepsin (FK228), a histone deacetylase inhibitor and its analogues in cancer Chemotherapy[J]","volume":"28","author":"Pojani","year":"2021","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40164-024-00507-5","article-title":"Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives[J]","volume":"13","author":"Pu","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104920_bib116","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1631\/jzus.B0920077","article-title":"DcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters[J]","volume":"10","author":"Q-l","year":"2009","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.critrevonc.2025.104920_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108360","article-title":"Discovery of novel selective HDAC6 inhibitors via a scaffold hopping approach for the treatment of idiopathic pulmonary fibrosis (IPF) in vitro and in vivo[J]","volume":"159","author":"Quan","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.critrevonc.2025.104920_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153396","article-title":"The clinical significance of histone deacetylase-8 in human breast cancer[J]","volume":"220","author":"Rahmani","year":"2021","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.critrevonc.2025.104920_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcdb.2025.103621","article-title":"The open and closed case for class I HDACs in cardiac development[J]","volume":"172","author":"Rajesth","year":"2025","journal-title":"Semin. Cell Dev. Biol."},{"issue":"29","key":"10.1016\/j.critrevonc.2025.104920_bib120","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1200\/JCO.2010.30.2307","article-title":"Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a national cancer institute organ dysfunction working group study[J]","volume":"28","author":"Ramalingam","year":"2010","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.critrevonc.2025.104920_bib121","doi-asserted-by":"crossref","first-page":"14171","DOI":"10.1021\/acs.jmedchem.5c01677","article-title":"Advancements in Hydrazide-Based HDAC inhibitors: a review of recent developments and therapeutic Potential[J]","volume":"68","author":"Raucci","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2025.104920_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2025.1579194","article-title":"Inhibition of class IIa HDACs reduces mutant HTT aggregation by affecting RNA stability[J]","volume":"18","author":"Reisbitzer","year":"2025","journal-title":"Front. Mol. Neurosci."},{"issue":"5619","key":"10.1016\/j.critrevonc.2025.104920_bib123","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/268462a0","article-title":"n-Butyrate causes histone modification in HeLa and friend erythroleukaemia cells[J]","volume":"268","author":"Riggs","year":"1977","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104920_bib124","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1158\/1078-0432.CCR-19-2214","article-title":"A phase II trial of pembrolizumab and vorinostat in recurrent metastatic head and neck squamous cell carcinomas and salivary gland Cancer[J]","volume":"26","author":"Rodriguez","year":"2020","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104920_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2025.149594","article-title":"Transcriptomic profiling and bioinformatics-driven statistical prioritization of CRC biomarkers: a step toward precision oncology[J]","volume":"964","author":"Saleh","year":"2025","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104920_bib126","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s12029-019-00338-2","article-title":"Histone deacetylase modifications by probiotics in colorectal Cancer[J]","volume":"51","author":"Salek Farrokhi","year":"2020","journal-title":"J. Gastrointest. Cancer"},{"issue":"21","key":"10.1016\/j.critrevonc.2025.104920_bib127","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1200\/JCO.22.02760","article-title":"Bevacizumab in combination with Oxaliplatin-Based chemotherapy as First-Line therapy in metastatic colorectal cancer: a randomized phase III Study[J]","volume":"41","author":"Saltz","year":"2023","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib128","doi-asserted-by":"crossref","first-page":"9951","DOI":"10.1038\/s41598-022-14197-8","article-title":"Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study[J]","volume":"12","author":"Savarese","year":"2022","journal-title":"Sci. Rep."},{"issue":"4-5","key":"10.1016\/j.critrevonc.2025.104920_bib129","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/path.6436","article-title":"Genetic deletion of histone deacetylase 6 prevents peritoneal fibrosis via suppression of heat shock protein 90 deacetylation[J]","volume":"266","author":"Shi","year":"2025","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-024-01551-8","article-title":"Advances in targeting histone deacetylase for treatment of solid tumors[J]","volume":"17","author":"Shi","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib131","first-page":"10","article-title":"Cancer statistics, 2025[J]","volume":"75","author":"Siegel","year":"2025","journal-title":"CA a Cancer Journal Clinicians"},{"issue":"50","key":"10.1016\/j.critrevonc.2025.104920_bib132","doi-asserted-by":"crossref","first-page":"22494","DOI":"10.1002\/anie.202006725","article-title":"Hydroxamic acids immobilized on resins (HAIRs): synthesis of Dual-Targeting HDAC inhibitors and HDAC degraders (PROTACs)[J]","volume":"59","author":"Sinatra","year":"2020","journal-title":"Angew. Chem. (Int. Ed. Engl. )"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104920_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041837","article-title":"Whole exome sequencing identifies APCDD1 and HDAC5 genes as potentially cancer predisposing in familial colorectal Cancer[J]","volume":"22","author":"Skopelitou","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104920_bib134","first-page":"155","article-title":"Targeted cancer Therapies[J]","volume":"103","author":"Smith","year":"2021","journal-title":"Am. Fam. Physician"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104920_bib135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.molcel.2019.09.016","article-title":"The control centers of biomolecular phase separation: how membrane surfaces, PTMs, and active processes regulate Condensation[J]","volume":"76","author":"Snead","year":"2019","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib136","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41392-025-02266-z","article-title":"Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance[J]","volume":"10","author":"Song","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib137","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010460","article-title":"HDAC and MEK inhibition synergistically suppresses HOXC6 and enhances PD-1 blockade efficacy in BRAFV600E-mutant microsatellite stable colorectal cancer[J]","volume":"13","author":"Sun","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib138","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10555-025-10253-7","article-title":"Epigenetic drugs in cancer therapy[J]","volume":"44","author":"Suraweera","year":"2025","journal-title":"Cancer Metastas.. Rev."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104920_bib139","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/17460441.2021.1877656","article-title":"An update on the emerging approaches for histone deacetylase (HDAC) inhibitor drug discovery and future perspectives[J]","volume":"16","author":"Su","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.critrevonc.2025.104920_bib140","article-title":"Efficacy of tucidinostat pre-emptive therapy for peripheral T-cell lymphoma after allogeneic stem cell transplantation[J]","author":"Takada","year":"2025","journal-title":"Intern. Med. (Tokyo Jpn. )"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104920_bib141","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1091\/mbc.e08-07-0759","article-title":"A histone deacetylase 4\/myogenin positive feedback loop coordinates denervation-dependent gene induction and suppression[J]","volume":"20","author":"Tang","year":"2009","journal-title":"Mol. Biol. Cell"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104920_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2019.01.007","article-title":"HDAC1 and HDAC2 regulate intermediate progenitor positioning to safeguard neocortical Development[J]","volume":"101","author":"Tang","year":"2019","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib143","first-page":"177","article-title":"Synergistic antitumor interaction between valproic acid, capecitabine and radiotherapy in colorectal cancer: critical role of p53[J]","volume":"36","author":"Terranova-Barberio","year":"2017","journal-title":"Journal Experimental Clinical Cancer Research CR"},{"key":"10.1016\/j.critrevonc.2025.104920_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102166","article-title":"Histone-acetyl epigenome regulates TGF-\u03b2 pathway-associated chemoresistance in colorectal cancer[J]","volume":"51","author":"Tian","year":"2025","journal-title":"Transl. Oncol."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104920_bib145","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1158\/1078-0432.CCR-21-0238","article-title":"Preclinical development and First-in-Human study of KA2507, a selective and potent inhibitor of histone deacetylase 6, for patients with refractory solid Tumors[J]","volume":"27","author":"Tsimberidou","year":"2021","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104920_bib146","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cell.2004.10.024","article-title":"Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis[J]","volume":"119","author":"Vega","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2025.104920_bib147","doi-asserted-by":"crossref","DOI":"10.1007\/s10815-025-03557-8","article-title":"Sirtuins, redox, and metabolic pathways in the brain of female PCOS mice[J]","author":"Vergara","year":"2025","journal-title":"J. Assist. Reprod. Genet."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib148","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16010054","article-title":"Role of histone deacetylase 6 and histone deacetylase 6 inhibition in colorectal Cancer[J]","volume":"16","author":"Vuleti\u0107","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.critrevonc.2025.104920_bib149","article-title":"Vascular normalization augments the Anti-tumor efficacy of combined HDAC inhibitor with immunotherapy in solid Tumors[J]","author":"Wang","year":"2025","journal-title":"Cancer Discov."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104920_bib150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2024.08.019","article-title":"Fusobacterium nucleatum facilitates anti-PD-1 therapy in microsatellite stable colorectal cancer[J]","volume":"42","author":"Wang","year":"2024","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104920_bib151","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.70577","article-title":"HBP-A attenuates knee osteoarthritis progression via MLK3\/P38\/HDAC4 Axis-Mediated dual protection of articular cartilage and Quadriceps[J]","volume":"29","author":"Wang","year":"2025","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.critrevonc.2025.104920_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2025.06.003","article-title":"Nutrient acquisition of gut microbiota: implications for tumor immunity[J]","volume":"114","author":"Wang","year":"2025","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104920_bib153","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41591-024-02813-1","article-title":"Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS\/pMMR colorectal cancer: a randomized phase 2 trial[J]","volume":"30","author":"Wang","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2025.104920_bib154","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-biochem-082520-125411","article-title":"Understanding the function of mammalian sirtuins and protein lysine Acylation[J]","volume":"90","author":"Wang","year":"2021","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104920_bib155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/FJC.0000000000001174","article-title":"Isoform-Selective HDAC inhibitor mocetinostat (MGCD0103) alleviates myocardial Ischemia\/Reperfusion injury via mitochondrial protection through the HDACs\/CREB\/PGC-1\u03b1 signaling Pathway[J]","volume":"79","author":"Wang","year":"2022","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"18","key":"10.1016\/j.critrevonc.2025.104920_bib156","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13184700","article-title":"Vorinostat (SAHA) and breast cancer: an Overview[J]","volume":"13","author":"Wawruszak","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104920_bib157","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11020148","article-title":"Histone deacetylase inhibitors and phenotypical transformation of cancer Cells[J]","volume":"11","author":"Wawruszak","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2025.104920_bib158","article-title":"Ketogenic diet and \u03b2-hydroxybutyrate inhibit HDAC1 to preserve vascular smooth muscle cell function in thoracic aortic aneurysm[J]","author":"Weng","year":"2025","journal-title":"J. Adv. Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104920_bib159","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.7150\/jca.66914","article-title":"Histone deacetylase (HDAC) 11 inhibits matrix metalloproteinase (MMP) 3 expression to suppress colorectal cancer metastasis[J]","volume":"13","author":"Wen","year":"2022","journal-title":"J. Cancer"},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104920_bib160","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/emboj.2010.136","article-title":"Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis[J]","volume":"29","author":"Wilting","year":"2010","journal-title":"EMBO J."},{"issue":"24","key":"10.1016\/j.critrevonc.2025.104920_bib161","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1038\/emboj.2013.243","article-title":"Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis[J]","volume":"32","author":"Winter","year":"2013","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104920_bib162","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2326-6066.CIR-15-0077-T","article-title":"HDAC inhibition upregulates PD-1 ligands in melanoma and augments immunotherapy with PD-1 Blockade[J]","volume":"3","author":"Woods","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104920_bib163","doi-asserted-by":"crossref","first-page":"125","DOI":"10.32604\/or.2023.028657","article-title":"Macrophage-derived SHP-2 inhibits the metastasis of colorectal cancer via Tie2-PI3K signals[J]","volume":"31","author":"Wu","year":"2023","journal-title":"Oncol. Res."},{"key":"10.1016\/j.critrevonc.2025.104920_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103746","article-title":"Anemoside B4 alleviates ulcerative colitis by attenuating intestinal oxidative stress and NLRP3 inflammasome via activating aryl hydrocarbon receptor through remodeling the gut microbiome and metabolites[J]","volume":"85","author":"Wu","year":"2025","journal-title":"Redox Biol."},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104920_bib165","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1021\/acs.jmedchem.9b00516","article-title":"Development of multifunctional histone deacetylase 6 degraders with potent antimyeloma Activity[J]","volume":"62","author":"Wu","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2025.104920_bib166","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3389\/fcell.2020.00812","article-title":"MicroRNA: another pharmacological avenue for colorectal Cancer?[J]","volume":"8","author":"Wu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2025.104920_bib167","article-title":"Rhodium-based metallodrugs for biological applications: current status and future perspectives[J]","volume":"33","author":"Xiang","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib168","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41392-020-0116-z","article-title":"Comprehensive review of targeted therapy for colorectal cancer[J]","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"16","key":"10.1016\/j.critrevonc.2025.104920_bib169","first-page":"4042","article-title":"Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel[J]","volume":"59","author":"Yamori","year":"1999","journal-title":"Cancer Res."},{"issue":"98","key":"10.1016\/j.critrevonc.2025.104920_bib170","doi-asserted-by":"crossref","first-page":"14848","DOI":"10.1039\/C9CC08509B","article-title":"Plasticity in designing PROTACs for selective and potent degradation of HDAC6[J]","volume":"55","author":"Yang","year":"2019","journal-title":"Chem. Commun. (Camb. Engl. )"},{"key":"10.1016\/j.critrevonc.2025.104920_bib171","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.biopha.2018.01.110","article-title":"Inhibitory effect of chidamide on the growth of human adenoid cystic carcinoma cells[J]","volume":"99","author":"Yang","year":"2018","journal-title":"Biomed. Pharmacother. = Biomed. Pharmacother."},{"key":"10.1016\/j.critrevonc.2025.104920_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101487","article-title":"LncRNA C9orf139 can regulate the progression of esophageal squamous carcinoma by mediating the miR-661\/HDAC11 axis[J]","volume":"24","author":"Yang","year":"2022","journal-title":"Transl. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104920_bib173","article-title":"Lactylation of HDAC1 confers resistance to ferroptosis in colorectal Cancer[J]","volume":"12","author":"Yang","year":"2025","journal-title":"Adv. Sci. (Weinheim Baden-Wurttemberg Germany)"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104920_bib174","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1021\/acsmedchemlett.0c00046","article-title":"Development of selective histone deacetylase 6 (HDAC6) degraders recruiting von Hippel-Lindau (VHL) E3 ubiquitin Ligase[J]","volume":"11","author":"Yang","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104920_bib175","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa368","article-title":"Serum profile of microRNAs linked to bone metabolism during sequential treatment for postmenopausal Osteoporosis[J]","volume":"105","author":"Yavropoulou","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104920_bib176","doi-asserted-by":"crossref","first-page":"10832","DOI":"10.1021\/acs.nanolett.3c03037","article-title":"Intra-articular histone deacetylase inhibitor microcarrier delivery to reduce Osteoarthritis[J]","volume":"23","author":"Ye","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.critrevonc.2025.104920_bib177","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.8493","article-title":"Inhibition of hepatoblastoma by ganoderma lucidum polysaccharide via the induction of HDAC4-p16-RB Axis-Mediated cellular Senescence[J]","author":"Ye","year":"2025","journal-title":"Phytother. Res. PTR"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib178","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-025-00796-2","article-title":"Upregulated astrocyte HDAC7 induces Alzheimer-like tau pathologies via deacetylating transcription factor-EB and inhibiting lysosome biogenesis[J]","volume":"20","author":"Ye","year":"2025","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib179","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/07357907.2021.1961265","article-title":"IRF1 inhibits Autophagy-Mediated proliferation of colorectal cancer via targeting ATG13[J]","volume":"40","author":"Yuan","year":"2022","journal-title":"Cancer Investig."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104920_bib180","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1182\/blood.2019895326","article-title":"HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms[J]","volume":"135","author":"Yue","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104920_bib181","doi-asserted-by":"crossref","DOI":"10.1111\/1750-3841.70250","article-title":"Inulin modulates gut microbiota and increases Short-Chain fatty acids levels to inhibit colon tumorigenesis in rat models: a systematic review and Meta-Analysis[J]","volume":"90","author":"Yu","year":"2025","journal-title":"J. Food Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib182","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s43897-025-00144-4","article-title":"Histone deacetylases repress the accumulation of licochalcone a by inhibiting the expression of flavonoid biosynthetic pathway-related genes in licorice (Glycyrrhiza inflata)[J]","volume":"5","author":"Zeng","year":"2025","journal-title":"Mol. Hortic."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104920_bib183","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1128\/MCB.01154-06","article-title":"Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally[J]","volume":"28","author":"Zhang","year":"2008","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib184","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2508426","article-title":"Implications of gut microbiota-mediated epigenetic modifications in intestinal diseases[J]","volume":"17","author":"Zhang","year":"2025","journal-title":"Gut Microbes"},{"key":"10.1016\/j.critrevonc.2025.104920_bib185","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.70077","article-title":"Role of histone deacetylase and inhibitors in cardiovascular Diseases[J]","author":"Zhang","year":"2025","journal-title":"Cell Prolif."},{"key":"10.1016\/j.critrevonc.2025.104920_bib186","article-title":"Mechanisms of HDACs in cancer development[J]","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"issue":"16","key":"10.1016\/j.critrevonc.2025.104920_bib187","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.3748\/wjg.v29.i16.2502","article-title":"Predictive value of presepsin and acylcarnitines for severity and biliary drainage in acute cholangitis[J]","volume":"29","author":"Zhang","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104920_bib188","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1039\/D5FO00422E","article-title":"Ketogenic diet attenuates microglia-mediated neuroinflammation by inhibiting NLRP3 inflammasome activation via HDAC3 inhibition to activate mitophagy in experimental autoimmune encephalomyelitis[J]","volume":"16","author":"Zhang","year":"2025","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib189","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41392-024-02097-4","article-title":"Digestive cancers: mechanisms, therapeutics and management[J]","volume":"10","author":"Zhan","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104920_bib190","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00280-021-04393-0","article-title":"ATF4-mediated microRNA-145\/HDAC4\/p53 axis affects resistance of colorectal cancer cells to 5-fluorouracil by regulating autophagy[J]","volume":"89","author":"Zhao","year":"2022","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104920_bib191","article-title":"New perspectives on postmenopausal osteoporosis: mechanisms and potential therapeutic strategies of sirtuins and oxidative Stress[J]","volume":"14","author":"Zhao","year":"2025","journal-title":"Antioxid. (Basel Switz. )"},{"key":"10.1016\/j.critrevonc.2025.104920_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111817","article-title":"TDH-11 inhibits the proliferation and colonization of colorectal cancer by reducing the activity of HDAC[J]","volume":"132","author":"Zhong","year":"2025","journal-title":"Cell. Signal."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104920_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33997","article-title":"Role of histone deacetylase inhibitors in non-neoplastic diseases[J]","volume":"10","author":"Zhou","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104920_bib194","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41389-025-00562-5","article-title":"NUCKS1 promotes invasion and metastasis of colorectal cancer by stabilizing HDAC2 and activating AKT[J]","volume":"14","author":"Zhu","year":"2025","journal-title":"Oncogenesis"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104920_bib195","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70275","article-title":"Incidence and immunopathology of myositis in rectal cancer patients treated with neoadjuvant immune checkpoint inhibitors and chemoradiotherapy: findings from the CHINOREC Trial[J]","volume":"6","author":"Zirnbauer","year":"2025","journal-title":"MedComm"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104920_bib196","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41375-025-02584-9","article-title":"HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy[J]","volume":"39","author":"Zrim\u0161ek","year":"2025","journal-title":"Leukemia"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825003087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825003087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:40:21Z","timestamp":1792986021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825003087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":196,"alternative-id":["S1040842825003087"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104920","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unlocking the therapeutic potential of HDAC inhibitors in colorectal cancer: Mechanisms, efficacy, and future perspectives","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104920"}}